Cargando…

ZFAND5 Is an Independent Prognostic Biomarker of Perihilar Cholangiocarcinoma

BACKGROUND: Cholangiocarcinoma (CCA) is a highly aggressive malignancy with extremely poor prognosis. Perihilar CCA (pCCA) is the most common subtype of CCA, but its biomarker study is much more lagged behind other subtypes. ZFAND5 protein can interact with ubiquitinated proteins and promote protein...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Pei, Wang, Yijia, Duan, Lingling
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9326020/ https://www.ncbi.nlm.nih.gov/pubmed/35912230 http://dx.doi.org/10.3389/fonc.2022.955670

Ejemplares similares

Exosomal Cripto-1 Serves as a Potential Biomarker for Perihilar Cholangiocarcinoma
por: Hu, Chunxiao, et al.
Publicado: (2021)

CT-Based Radiomics Analysis for Noninvasive Prediction of Perineural Invasion of Perihilar Cholangiocarcinoma
por: Zhan, Peng-Chao, et al.
Publicado: (2022)

Bile metabolites as diagnostic biomarkers for perihilar cholangiocarcinoma
por: Zhang, DengYong, et al.
Publicado: (2023)

Podoplanin is an important stromal prognostic marker in perihilar cholangiocarcinoma
por: Obulkasim, Halmurat, et al.
Publicado: (2018)

Establishment and validation of a prognostic nomogram for patients with resectable perihilar cholangiocarcinoma
por: Chen, Peizhan, et al.
Publicado: (2016)

Development and Validation of a Prognostic Model to Predict Recurrence-Free Survival After Curative Resection for Perihilar Cholangiocarcinoma: A Multicenter Study
por: Liu, Zhi-Peng, et al.
Publicado: (2022)

Association of systemic inflammation index with survival in patients with advanced perihilar cholangiocarcinoma treated with interventional therapy
por: Li, Jinyu, et al.
Publicado: (2022)

Targeted Therapies for Perihilar Cholangiocarcinoma
por: Gray, Simon, et al.
Publicado: (2022)

Preoperative Management of Perihilar Cholangiocarcinoma
por: Ellis, Ryan J., et al.
Publicado: (2022)

Vascular Resection in Perihilar Cholangiocarcinoma
por: Serrablo, Alejandro, et al.
Publicado: (2021)

Irreversible Electroporation Treatment With Intraoperative Biliary Stenting for Unresectable Perihilar Cholangiocarcinoma: A Pilot Study
por: Yang, Po-Chih, et al.
Publicado: (2021)

The prognostic impact of preoperative body composition in perihilar and intrahepatic cholangiocarcinoma
por: Lurje, Isabella, et al.
Publicado: (2022)

Assessment of the prognostic value of the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in perihilar cholangiocarcinoma patients following curative resection: A multicenter study of 333 patients
por: Ge, Ming-Yang, et al.
Publicado: (2023)

Perihilar-cholangiocarcinoma: what really matters?
por: Di Benedetto, Fabrizio, et al.
Publicado: (2022)

Nationwide treatment and outcomes of perihilar cholangiocarcinoma
por: van Keulen, Anne‐Marleen, et al.
Publicado: (2021)

Value of palliative surgery in perihilar cholangiocarcinoma
por: Dondorf, Felix, et al.
Publicado: (2023)

Prognostic Relevance of the Eighth Edition of TNM Classification for Resected Perihilar Cholangiocarcinoma
por: Hau, Hans-Michael, et al.
Publicado: (2020)

A Novel Nomogram Based on Log Odds of Metastatic Lymph Nodes to Predict Overall Survival in Patients With Perihilar Cholangiocarcinoma After Surgery
por: Zou, Wenbo, et al.
Publicado: (2021)

Current Perspectives on the Surgical Management of Perihilar Cholangiocarcinoma
por: Hewitt, D. Brock, et al.
Publicado: (2022)

Eligibility for Liver Transplantation in Patients with Perihilar Cholangiocarcinoma
por: Vugts, Jaynee J. A., et al.
Publicado: (2020)

Current Perspectives in Liver Transplantation for Perihilar Cholangiocarcinoma
por: Giovinazzo, Francesco, et al.
Publicado: (2023)

PD-1+ T-Cells Correlate with Nerve Fiber Density as a Prognostic Biomarker in Patients with Resected Perihilar Cholangiocarcinoma
por: Tan, Xiuxiang, et al.
Publicado: (2022)

Protocol for the STRONG trial: stereotactic body radiation therapy following chemotherapy for unresectable perihilar cholangiocarcinoma, a phase I feasibility study
por: Koedijk, Merel S, et al.
Publicado: (2018)

Inter- and intrafraction dose variations in robotic stereotactic body radiation therapy (SBRT) for perihilar cholangiocarcinoma in the prospective phase I STRONG trial
por: Paronetto, Chiara, et al.
Publicado: (2023)

Prognostic Impact of Perioperative CA19-9 Levels in Patients with Resected Perihilar Cholangiocarcinoma
por: Lee, Jong Woo, et al.
Publicado: (2021)

Hepatopancreatoduodenectomy for perihilar cholangiocarcinoma following laparoscopic total gastrectomy
por: Chiba, Naokazu, et al.
Publicado: (2017)

PD-L1 expression in perihilar and intrahepatic cholangiocarcinoma
por: Fontugne, Jacqueline, et al.
Publicado: (2017)

Leakage and Stenosis of the Hepaticojejunostomy Following Surgery for Perihilar Cholangiocarcinoma (†)
por: Bednarsch, Jan, et al.
Publicado: (2020)

Practical review for diagnosis and clinical management of perihilar cholangiocarcinoma
por: Dondossola, Daniele, et al.
Publicado: (2020)

Major hepatectomy with combined vascular resection for perihilar cholangiocarcinoma
por: Sugiura, T, et al.
Publicado: (2021)

Major hepatectomy for perihilar cholangiocarcinoma in elderly patients: is it reasonable?
por: Ripamonti, L., et al.
Publicado: (2021)

Liver transplantation for perihilar cholangiocarcinoma is not a provocative idea
por: Chebaro, Alexandre, et al.
Publicado: (2023)

Galanin System in the Human Bile Duct and Perihilar Cholangiocarcinoma
por: Huber, Sara, et al.
Publicado: (2023)

Dual-Specificity Phosphatase 11 Is a Prognostic Biomarker of Intrahepatic Cholangiocarcinoma
por: Xu, Lin, et al.
Publicado: (2021)

Feasibility and Efficacy of Adjuvant Chemotherapy With Gemcitabine After Liver Transplantation for Perihilar Cholangiocarcinoma - A Multi-Center, Randomized, Controlled Trial (pro-duct001)
por: Schmelzle, Moritz, et al.
Publicado: (2022)

Identification of therapeutic targets and prognostic biomarkers in cholangiocarcinoma via WGCNA
por: Xu, Lei, et al.
Publicado: (2022)

Impact of perioperative blood transfusion on long-term survival in patients with different stages of perihilar cholangiocarcinoma treated with curative resection: A multicentre propensity score matching study
por: Liu, Zhi-Peng, et al.
Publicado: (2022)

Initial drainage‐related prognostic factors for perihilar cholangiocarcinoma: A single‐center retrospective study
por: Sato, Katsuhiko, et al.
Publicado: (2022)

Prognostic impact of preoperative skeletal muscle change from diagnosis to surgery in patients with perihilar cholangiocarcinoma
por: Hayashi, Koki, et al.
Publicado: (2022)

Impact of Positive Radial Margin on Recurrence and Survival in Perihilar Cholangiocarcinoma
por: D’Amico, Francesco Enrico, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_pgtksc9td33badplolskh01mgo